Literature DB >> 23988767

Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).

Alex J Mackay1, Gavin C Donaldson, Anant R C Patel, Richa Singh, Beverly Kowlessar, Jadwiga A Wedzicha.   

Abstract

Uncertainty exists over the ability of the exacerbations of chronic pulmonary disease tool (EXACT) patient-reported outcome diary to quantify exacerbation severity and frequency. To clarify this, we investigated the ability of the EXACT to assess severity of exacerbations and examined the relationship between exacerbations diagnosed using London chronic obstructive pulmonary disease (COPD) cohort diary cards, physician review and symptom-defined events using the EXACT. 58 patients enrolled in the London Chronic Obstructive Pulmonary Disease (COPD) cohort prospectively completed the EXACT during 128 cohort diary card-defined exacerbations between January 2010 and April 2012. Mean ± sd EXACT scores increased from 42.6 ± 8.6 at baseline to 48.0 ± 8.6 at exacerbation onset (p<0.001), and rose further to a maximum score of 54.1 ± 8.9. Maximum EXACT scores were significantly higher in treated than untreated events. Time taken for EXACT scores to return to baseline was significantly related to symptom recovery time as judged by London COPD cohort diary cards, and to peak expiratory flow rate recovery. ∼50% of both diary card-defined and healthcare utilisation exacerbations crossed the EXACT event threshold. However, only 27.9% of diary card-defined and 34.6% of healthcare utilisation exacerbations fully met the criteria for an EXACT event. Patients exhibited smaller rises in the EXACT score at exacerbation as baseline disease severity increased. The EXACT is an effective method of evaluating chronic obstructive pulmonary disease exacerbation severity. However, concerns remain about the ability of the EXACT to accurately detect exacerbations.

Entities:  

Mesh:

Year:  2013        PMID: 23988767     DOI: 10.1183/09031936.00110913

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study.

Authors:  Daniel Sanchez-Morillo; Miguel Angel Fernandez-Granero; Antonio León Jiménez
Journal:  Med Biol Eng Comput       Date:  2015-03-01       Impact factor: 2.602

Review 2.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

3.  The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function.

Authors:  Lindsey T Murray; Nancy K Leidy
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

4.  Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

Authors:  Gavin C Donaldson; Martin Law; Beverly Kowlessar; Richa Singh; Simon E Brill; James P Allinson; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

5.  Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics.

Authors:  Yumin Zhou; Piet L B Bruijnzeel; Christopher McCrae; Jinping Zheng; Ulf Nihlen; Rong Zhou; Marleen Van Geest; Anna Nilsson; Sinela Hadzovic; Monika Huhn; Ziad Taib; Yi Gu; Jiaxing Xie; Pixin Ran; Rongchang Chen; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 6.  Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Authors:  Alvar Agustí; Peter M Calverley; Marc Decramer; Robert A Stockley; Jadwiga A Wedzicha
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

7.  Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study.

Authors:  Yan Yin; Jinfu Xu; Shaoxi Cai; Yahong Chen; Yan Chen; Manxiang Li; Zhiqiang Zhang; Jian Kang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-05

8.  Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.

Authors:  Stefan M Frent; Kenneth R Chapman; Michael Larbig; Alexander Mackay; Robert Fogel; Florian S Gutzwiller; Steven Shen; Francesco Patalano; Donald Banerji; Konstantinos Kostikas; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

9.  Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis.

Authors:  Hyun Woo Lee; Hyung Jun Kim; Eun Jin Jang; Chang-Hoon Lee
Journal:  Respiration       Date:  2021-05-10       Impact factor: 3.580

10.  Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations.

Authors:  Neil Patel; Kathryn Kinmond; Pauline Jones; Pamela Birks; Monica A Spiteri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.